Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 16,560
-480 (-2.82%)
At close: Feb 6, 2026
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 743.34 billion as of February 6, 2026. Its market cap has increased by 277.21% in one year.
Market Cap
743.34B
Enterprise Value
689.93B
Revenue
46.65B
Ranking
n/a
PE Ratio
10.94
Stock Price
16,560.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 743.34B, an increase of 297.70%. That is a compound annual growth rate of 237.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 743.34B | -14.54% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 957.60B |
| Medy-Tox | 887.30B |
| GI Innovation | 839.93B |
| Pharmicell | 803.45B |
| Proteina | 790.92B |
| Green Cross Holdings | 677.39B |
| Genomictree | 544.78B |
| SillaJen | 516.61B |